| Serial Number | 79394301 |
| Word Mark | NEC |
| Filing Date | Wednesday, November 8, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
| Description of Mark | The mark consists of the letters "NEC" in stylized block text. |
| Goods and Services | Downloadable and recorded computer software for use in analyzing and identifying genome information; Downloadable and recorded computer software for medical process management of individual personalized treatment; Downloadable and recorded computer software for patient stratification; Downloadable and recorded operating system computer software for use with companion diagnostic medical devices; Downloadable and recorded computer software platforms for use in medical data management; Downloadable and recorded computer operating programs; Downloadable and recorded computer operating system software; computers and computer hardware; computer network servers; computer peripheral apparatus; Downloadable and recorded computer software and downloadable application software for collecting and storage of patient data and medical information; Data processing equipment in the nature of data processing systems for collecting and storage of patient data and medical information |
| Goods and Services | Vaccines; vaccines preparations; vaccine preparations for the prevention and treatment of cancer, infection and auto immune disease; pharmaceuticals and pharmaceutical preparations for human use for the prevention and treatment of cancer, infection and auto immune disease; companion diagnostic agents for medical use; pharmaceutical preparations for the treatment and prevention of cancer, infection and auto immune disease namely cellular therapeutics; pharmaceutical preparations for the treatment of cell related viral diseases; reagent paper for medical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes, namely, drinks for babies; food for babies; dietary supplements for animals |
| Goods and Services | Collection of information into computer databases in the field of genetic and genomic information and life science; Collection of genome information into computer databases for medical purposes; collection of information into computer databases in the field of medical information |
| Goods and Services | Providing medical information related to the preservation of genome information for medical purposes; Providing medical information in the nature of collected genome information; providing medical information in the field of cellular therapeutics; medical diagnostic testing and monitoring services in the field of cellular therapeutics, namely, cell therapy; medical assistance services in the nature of information about genetic testing and medical information provided to remote medical professionals via the Internet and global computer networks through the use of genome sequence information, medical images, diagnostic test results, and data storage and retrieval systems; medical services relating to the collection, processing and preservation of biological samples; collection and preservation of biological samples, namely, human cells; medical laboratory services for the analysis of biological samples; medical analysis services for diagnostic and treatment provided by medical laboratories relating to cell, tissue, gene expression, gene sequence, genome annotation, transcriptome characteristic analysis, genome mapping; provision of medical information; physical examination services; providing an internet website for medical professionals and medical patients featuring medical information and medical data which users process, exchange and access in real time |
| Goods and Services | Research and development of vaccines and medicines; scientific research in the nature of conducting clinical trials for others; research and development of medicines in the nature of companion diagnostic agent; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; scientific research in the field of genetics; medical research; design and development of computer hardware and software for use in companion diagnostic; designing of machines, apparatus, instruments and their parts or systems composed of such machines, apparatus and instruments; technology advisory and consultancy services relating to the design and development of computer hardware; computer programming; medical and scientific research in the field of gene analysis; Scientific and technological services, namely, genome research, testing, analysis, and evaluation of genome samples for scientific research purposes and providing information thereof; Scientific and technological services, namely, investigation and analysis of genome samples for scientific research purposes; providing on-line non downloadable software for use in analyzing and identifying genome information; providing on-line non downloadable software for medical process management of individual personalized treatment; providing on-line non downloadable software for patient stratification; providing on-line non downloadable operating system software for use with companion diagnostic medical devices; platform as a service (PaaS) featuring computer software platforms for use in medical data management; design and development of computer software for medical data analysis and management; rental of computers; providing temporary use of on-line non- downloadable cloud computing software and computer programs on data networks for medical data management; software as a service (SaaS) featuring software for medical data management; research and development in the field of cellular therapeutics; structural and functional analysis of genomes; Providing information about medical research, namely, genome information analysis; Scientific and technological services, namely, providing scientific analysis in the field of genomic data; providing on-line non downloadable software for use in collecting, analyzing, evaluating, interpreting and predicting genetic and genomic information; providing science information in the fields of genetic and genomic information and life science; Biological research in the nature of analysis of biological samples |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nippon Denki Kabushiki Kaisha (NEC Corporation) |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Nippon Denki Kabushiki Kaisha (NEC Corporation) |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Thursday, April 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, May 2, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, May 10, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 10, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, June 17, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 23, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, October 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 26, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, June 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, July 23, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, November 8, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 8, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 8, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 4, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 10, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 8, 2024 | EXAMINERS AMENDMENT -WRITTEN |